Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
17 sept. 2024 09h00 HE
|
Athira Pharma, Inc.
ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical trial with completion expected by year end 2024 and commencement of dosing of...
PolTREG Treg cell therapy for patients with type-1 diabetes shows long-term clinical remission and insulin independence
09 sept. 2024 01h00 HE
|
PolTREG S.A.
PTG-007 cell therapy resulted in clinical remission in some patients for up to 12 yearsA proportion of patients remained insulin-independent for up to 24 monthsPTG-007 ready to enter pivotal studyData...
Actimed Therapeutics Announces US FDA Grant of Orphan Drug Designation to S-oxprenolol (ACM-002) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
04 sept. 2024 03h00 HE
|
Actimed Therapeutics
London, UK – 4th September 2024. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and...
Harness Therapeutics Appoints Experienced R&D Executive and Physician-Scientist, Dr Paulo Fontoura, as Non-Executive Director
04 sept. 2024 03h00 HE
|
Harness Therapeutics
Dr Paulo Fontoura brings 20 years’ experience of working in the pharma industry, with the most recent 16 years focusing on translational medicine and clinical development approaches for one of the...
Fitness World Canada Partners with Augie’s Quest in the Mission to Cure ALS
03 sept. 2024 11h03 HE
|
Fitness World
VANCOUVER, British Columbia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- This September, Fitness World Canada joins forces with Augie’s Quest, an organization dedicated to finding a cure for ALS (Amyotrophic...
EverythingALS Launches New Mobile App: A Comprehensive Research and Life Navigation Tool for the ALS Community
26 août 2024 09h00 HE
|
EverythingALS
EverythingALS is proud to announce the launch of its new mobile app, now available on both the iOS and Android marketplaces.
MDA Kicks Off Muscular Dystrophy Awareness Month in September with ‘30 Days of Strength’ Campaign with Hundreds of Events to Advance Research and Care for the Neuromuscular Disease Community
26 août 2024 08h58 HE
|
Muscular Dystrophy Association
New York, Aug. 26, 2024 (GLOBE NEWSWIRE) -- September marks the kick-off of the Muscular Dystrophy Association (MDA) ‘National Muscular Dystrophy Awareness Month’ to raise awareness and critical...
Project Mosaic Launches to Bring “Biopsies” to ALS Drug Development
21 août 2024 13h10 HE
|
Project Mosaic
Project Mosaic is proud to announce the launch of a groundbreaking initiative aimed at revolutionizing ALS drug development.
Muscular Dystrophy Association International Association of Fire Fighters Launch 420 Fill the Boot Fundraisers in Cities Across America Labor Day Weekend for the Muscular Dystrophy Association
19 août 2024 09h15 HE
|
Muscular Dystrophy Association
New York, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) in partnership with the International Association of Fire Fighters (IAFF) kick off more than 420 Fill the Boot...
Tiziana Life Sciences Appoints New Chief Executive Officer
19 août 2024 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...